The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cells
James W. Welsh(The University of Texas MD Anderson Cancer Center), Baldassarre Stea(University of Arizona Cancer Center)
Cited by 114
Related Papers
Combination treatment with radiotherapy and a novel oxidative phosphorylation inhibitor overcomes PD-1 resistance and enhances antitumor immunity
|Journal for ImmunoTherapy of Cancer|2020|93
Bone morphogenetic protein 7 promotes resistance to immunotherapy
|Nature Communications|2020|58
NLRP3 agonist enhances radiation-induced immune priming and promotes abscopal responses in anti-PD1 resistant model
|Cancer Immunology Immunotherapy|2023|17
Low-Dose Radiation Decreases Cancer-Associated Fibroblasts and May Increase T-Cell Trafficking into Tumors
|International Journal of Radiation Oncology*Biology*Physics|2020|7